FDA Nanotechnology Public Meeting

This web page includes the transcripts of a public meeting held by the U.S. Food and Drug Administration (FDA) that was intended to assist the Agency in implementing the recommendations of the Nanotechnology Task Force Report. The meeting covered public comments and concerns on the use of engineered nanomaterials in medical devices and diagnostics, food additives and dietary supplements, prescription and over-the-counter drugs, and cosmetics.